Net loss of Welcure Drugs & Pharmaceuticals reported to Rs 0.02 crore in the quarter ended March 2024 as against net profit of Rs 0.17 crore during the previous quarter ended March 2023. There were no Sales reported in the quarter ended March 2024 and during the previous quarter ended March 2023.For the full year,net loss reported to Rs 0.18 crore in the year ended March 2024 as against net profit of Rs 0.10 crore during the previous year ended March 2023. There were no Sales reported in the year ended March 2024 and during the previous year ended March 2023.Powered by Capital Market - Live News

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 10 June 2024.Powered by Capital Market - Live News

Welcure Drugs & Pharmaceuticals has postponed the meeting of the Board of Directors which was scheduled to be held on 28 May 2024. The meeting will now be held on 30 May 2024.Powered by Capital Market - Live News

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 May 2024.Powered by Capital Market - Live News

Welcure Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 28 March 2024.Powered by Capital Market - Live News